Results 91 to 100 of about 61,198,315 (136)

A case report of malignant transformation in neurofibromatosis type 1: pain and rapid growth as key indicators for early biopsy. [PDF]

Front Oncol
Zhao Y, Cao JY, Li Y, Huo JY, Zhao ZW, Xue L, Li J, Duan CZ.   +7 more
europepmc   +1 more source

Ganglioneuroblastoma associated with neurofibromatosis type 1: a case report with a systematic review. [PDF]

Front Oncol
Zhang Q, Su S, Geng G, Bai Y, Hu W, Zhang W, Zhang H, Wang G.   +7 more
europepmc   +1 more source

Case Report: Somatic <i>NF2</i> mutation in a vestibular schwannoma arising in a patient with neurofibromatosis type 1. [PDF]

Front Oncol
Shogaku M, Yamada H, Yamada S, Fujinami R, Yamada S, Tanikawa M, Okuno Y, Mase M.   +7 more
europepmc   +1 more source

Utility of 18F-FDG PET/CT in the Surveillance of Patients With Neurofibromatosis Type 1. [PDF]

Neurol Genet
Tanase MG, Djilani L, Lamontagne R, Derbel R, Baril M, Roy V, Blais M, Buteau FA, Khuong HT, Gros-Louis F, Leclerc M, Dupre N.   +11 more
europepmc   +1 more source

The interconnection of multiple sclerosis and neurofibromatosis type 1: A single institution retrospective study and systematic review. [PDF]

Mult Scler J Exp Transl Clin
Bazer DA, Tobin GE, Woller-Li N, Spann M, Romo CG.   +4 more
europepmc   +1 more source

Skin lesions in patients treated with growth hormone and those with growth hormone excess: a current overview. [PDF]

Front Med (Lausanne)
Matwiejuk M, Myśliwiec H, Miklosz A, Chabowski A, Flisiak I.   +4 more
europepmc   +1 more source

Isolated Rectal Neurofibroma in the Absence of Neurofibromatosis: Report and Review of Molecular Implications. [PDF]

Eur J Case Rep Intern Med
Karam K, Charro K, Alirkilicarslan A, Morini A, Rakotobe J, Brousset E, Locher C.   +6 more
europepmc   +1 more source

Genetic and non-genetic factors influencing phenotypic variability in neurofibromatosis type 1. [PDF]

Orphanet J Rare Dis
Clissa PB, Sanabani SS.
europepmc   +1 more source